Third Rock Ventures III, L.P.

Insider Reports History

Location
Boston, MA
Signature
/s/ Kevin Gillis, Chief Operating Officer of TRV GP III, LLC, general partner of Third Rock Ventures GP III, L.P., general partner of Third Rock Ventures III, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Third Rock Ventures III, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Revolution Medicines, Inc. 10%+ Owner Common Stock 5,104,130 $137,811,510 $27.00 08 Jun 2022 Direct
PLIANT THERAPEUTICS, INC. 10%+ Owner Common Stock 2,132,867 $36,749,298 $17.23 29 Nov 2022 Indirect
Nurix Therapeutics, Inc. 10%+ Owner Common Stock 3,422,549 $34,236,100 $10.00 06 May 2021 Direct
PLIANT THERAPEUTICS, INC. 10%+ Owner Common Stock 1,839,160 $31,688,727 $17.23 29 Nov 2022 Direct
Voyager Therapeutics, Inc. 10%+ Owner Common Stock 3,185,291 $22,774,831 $7.15 02 Feb 2023 Direct
Fulcrum Therapeutics, Inc. 10%+ Owner Common Stock 2,343,154 $7,755,840 $3.31 13 Dec 2022 Indirect
Fulcrum Therapeutics, Inc. 10%+ Owner Common Stock 1,962,202 $6,494,889 $3.31 13 Dec 2022 Direct
Jounce Therapeutics, Inc. 10%+ Owner Common Stock 1,148,780 $2,125,243 $1.85 12 Nov 2021 Direct
Nurix Therapeutics, Inc. 10%+ Owner Common Stock 86,799 $868,259 $10.00 06 May 2021 Indirect
Jounce Therapeutics, Inc. 10%+ Owner Common Stock 283,858 $525,137 $1.85 12 Nov 2021 Indirect
Revolution Medicines, Inc. 10%+ Owner Common Stock 0 $27.00 08 Jun 2022 Indirect

Insider Reports Filed by Third Rock Ventures III, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VYGR Voyager Therapeutics, Inc. 02 Feb 2023 1 $0 4 10%+ Owner 06 Feb 2023, 15:30
VYGR Voyager Therapeutics, Inc. 30 Jan 2023 3 -$3,587,443 4 10%+ Owner 01 Feb 2023, 18:26
VYGR Voyager Therapeutics, Inc. 27 Jan 2023 1 -$451,000 4 10%+ Owner 31 Jan 2023, 15:30
VYGR Voyager Therapeutics, Inc. 24 Jan 2023 2 -$1,388,000 4 10%+ Owner 26 Jan 2023, 16:23
VYGR Voyager Therapeutics, Inc. 20 Jan 2023 2 -$1,413,300 4 10%+ Owner 24 Jan 2023, 17:20
FULC Fulcrum Therapeutics, Inc. 13 Dec 2022 1 $0 4 10%+ Owner 15 Dec 2022, 15:30
PLRX PLIANT THERAPEUTICS, INC. 29 Nov 2022 1 $0 4 10%+ Owner 01 Dec 2022, 15:47
PLRX PLIANT THERAPEUTICS, INC. 20 Sep 2022 1 $0 4 10%+ Owner 22 Sep 2022, 16:59
VYGR Voyager Therapeutics, Inc. 24 Aug 2022 2 -$2,157,329 4 10%+ Owner 26 Aug 2022, 16:15
VYGR Voyager Therapeutics, Inc. 16 Aug 2022 1 -$775,874 4 10%+ Owner 18 Aug 2022, 16:15
VYGR Voyager Therapeutics, Inc. 12 Aug 2022 2 -$2,950,083 4 10%+ Owner 16 Aug 2022, 16:22
RVMD Revolution Medicines, Inc. 08 Jun 2022 1 -$8,502,995 4 10%+ Owner 10 Jun 2022, 19:07
/report/000089924321044916-third-rock-ventures-iii-l-p-2021-11-12 Jounce Therapeutics, Inc. 12 Nov 2021 1 -$15,922,000 4 10%+ Owner 16 Nov 2021, 18:57
FULC Fulcrum Therapeutics, Inc. 10 Nov 2021 1 $0 4 10%+ Owner 12 Nov 2021, 16:26
FULC Fulcrum Therapeutics, Inc. 22 Sep 2021 1 $0 4 10%+ Owner 24 Sep 2021, 16:13
NRIX Nurix Therapeutics, Inc. 06 May 2021 1 $0 4 10%+ Owner 10 May 2021, 16:41